Linda Rainey, Mireille Broeders, Daniëlle van der Waal, and colleagues published three papers last month on the future implementation of risk-based breast cancer screening and prevention.Increased knowledge of breast cancer risk factors provides an opportunity to shift from one-size-fits-all screening to a personalised approach, establishing screening and prevention policy based on women’s individual risk of developing breast cancer. Potential implementation of this new paradigm is likely to present considerable challenges, and requires the support from eligible women to facilitate uptake.
Our systematic review of women’s perceptions showed that women carefully review their perceived susceptibility to breast cancer when considering the adoption of this novel screening and prevention programme. Their decisions about participation are based on a cost-benefit analysis of adopting tailored screening, risk-reducing medication, lifestyle changes, and/or prophylactic surgery, whilst taking into account their own perceived competence, autonomy, relatedness to others, and personal preference.
To obtain further insights on acceptability, we performed a mixed-methods study with healthcare professionals from the Netherlands, Sweden, and the United Kingdom who identified five themes that could impact women’s decision-making: (1) Anxiety/worry, (2) Proactive approach, (3) Reassurance, (4) Lack of knowledge, and (5) Organisation of risk assessment and feedback. Dutch and British professionals specifically expressed concerns about the acceptability of a heterogeneous screening policy, suggesting women will question their risk feedback and assigned pathway of care. Swedish professionals emphasised the potential impact on family relations.
Our review of future organisational implications of introducing risk-based breast cancer screening and prevention shows that significant changes in policy and practice are warranted. Feasibility of implementation depends on how healthcare is funded and arranged, and potentially varies between countries. Pilot studies of risk assessment and prevention counselling in primary care settings have highlighted a need for extensive additional training on risk (communication) and prevention, the impact on workflow, and professionals' personal discomfort breaching the topic with women. Additionally, gaps in risk estimation, psychological, ethical and legal consequences will need to be addressed.
Women's perceptions of the adoption of personalised risk-based breast cancer screening and primary prevention: a systematic review.
Rainey L, van der Waal D, Wengström Y, Jervaeus A, Broeders MJM.
Women's decision-making regarding risk-stratified breast cancer screening and prevention from the perspective of international healthcare professionals.
Rainey L, van der Waal D, Donnelly LS, Evans DG, Wengström Y, Broeders M.
Are we ready for the challenge of implementing risk-based breast cancer screening and primary prevention?
Rainey L, van der Waal D, Jervaeus A, Wengström Y, Evans DG, Donnelly LS, Broeders MJM.
Linda Rainey, Mireille Broeders, and Daniëlle van der Waal are all members of theme Women’s cancers.
Related news items
The PRIDE Study Evaluation of online methods of data collection16 January 2020
In Paediatric and Perinatal Epidemiology RIHS researchers Marleen van Gelder and Nel Roeleveld described the recruitment methods and online data collection within the PRIDE Study, the largest Dutch birth cohort study.read more
Laparoscopy reduces the number of adhesions but it is still too high14 January 2020
Adhesions after abdominal surgery cause too many re-admissions. Although keyhole surgery reduces the number of adhesions and the complications associated with them, the total disease burden remains high, as reported in The Lancet by RIHS researcher Richard ten Broek and colleagues.read more
Radboud Talks 2020 scientific pitch competition14 January 2020
The next edition of Radboud Talks will take place in the spring. During this academic pitch competition, young researchers will be given the opportunity to share their stories with a large audience. In a three-minute presentation, you will talk about your research in a fun and accessible manner.read more
Review Sanne Frambach accepted by Pharmacological Reviews13 January 2020
In this review entitled 'Brothers in arms: ABCA1 and ABCG1-mediated cholesterol efflux as promising targets in cardiovascular disease treatment', RIMLS researcher Sanne Frambach, describe the possibilities for stimulating cellular efflux.read more
Prostate cancer can now be diagnosed better using artificial intelligence9 January 2020
RIHS researchers Wouter Bulten and Geert Litjens have developed a ‘deep learning’ system that is better than most pathologists at determining the aggressiveness of prostate cancer. The Artificial Intelligence system taught itself to identify prostate cancer based on data from over 1200 patients.read more